The Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic Steatohepatitis
Public ClinicalTrials.gov record NCT04134091. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2, randomized, double-blind, placebo controlled, three arm study in adult men with biopsy confirmed NASH. The study is aimed at evaluating efficacy and tolerability of LPCN 1144 in adult men with NASH.
Study identification
- NCT ID
- NCT04134091
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 56 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 27, 2019 (Actual)
- Primary completion
- Jun 24, 2021 (Actual)
- Completion
- Jun 24, 2021 (Actual)
- Last update posted
- Dec 14, 2023
2019 – 2021
United States locations
- U.S. sites
- 19
- U.S. states
- 8
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| TriWest Research Associates, LLC | El Cajon | California | 92020 | — |
| United Medical Doctors | Murrieta | California | 92563 | — |
| Inland Empire Liver Foundation | Rialto | California | 92377 | — |
| Clinical Trials Research | Roseville | California | 95661 | — |
| Meridien Research-Maitland | Maitland | Florida | 32751 | — |
| Clinical Pharmacology of Miami, LLC | Miami | Florida | 33014 | — |
| Sensible Healthcare, LLC | Ocoee | Florida | 34761 | — |
| Tandem Clinical Research | Marrero | Louisiana | 70072 | — |
| Jubilee Clinical Research, Inc. | Las Vegas | Nevada | 89106 | — |
| Clinical Research of South Nevada | Las Vegas | Nevada | 89121 | — |
| Awasty Research Network | Marion | Ohio | 43302 | — |
| R&H Clinical Research | Katy | Texas | 77494 | — |
| Sun Research Institute | San Antonio | Texas | 78215 | — |
| Endeavor Clinical Trials | San Antonio | Texas | 78229 | — |
| Clinical Trial Network-Houston | Spring | Texas | 77386 | — |
| Pioneer Research Soultions | Sugar Land | Texas | 77479 | — |
| Advanced Clinical Research - Gut Whisperer | Riverton | Utah | 84065 | — |
| Granger Medical Clinic | West Valley City | Utah | 84120 | — |
| Manassas Clinical Research Center | Manassas | Virginia | 20110 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04134091, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 14, 2023 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04134091 live on ClinicalTrials.gov.